This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200711-1754OCv1 178/3/218    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haldar, P. Articles by Green, R. H. Search for Related Content PubMed PubMed Citation Articles by Haldar, P. Articles by Green, R. H.

Cluster Analysis and Clinical Asthma Phenotypes

¹ Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; and ² Department of General Practice, University of Aberdeen, Aberdeen, United Kingdom

Correspondence and requests for reprints should be addressed to Dr. P. Haldar, M.R.C.P., Institute for Lung Health, Glenfield Hospital, Leicester, LE3 9QP, UK. E-mail: ph62{at}le.ac.uk

Rationale: Heterogeneity in asthma expression is multidimensional, including variability in clinical, physiologic, and pathologic parameters. Classification requires consideration of these disparate domains in a unified model.

Objectives: To explore the application of a multivariate mathematical technique, k-means cluster analysis, for identifying distinct phenotypic groups.

Methods: We performed k-means cluster analysis in three independent asthma populations. Clusters of a population managed in primary care (n = 184) with predominantly mild to moderate disease, were compared with a refractory asthma population managed in secondary care (n = 187). We then compared differences in asthma outcomes (exacerbation frequency and change in corticosteroid dose at 12 mo) between clusters in a third population of 68 subjects with predominantly refractory asthma, clustered at entry into a randomized trial comparing a strategy of minimizing eosinophilic inflammation (inflammation-guided strategy) with standard care.

Measurements and Main Results: Two clusters (early-onset atopic and obese, noneosinophilic) were common to both asthma populations. Two clusters characterized by marked discordance between symptom expression and eosinophilic airway inflammation (early-onset symptom predominant and late-onset inflammation predominant) were specific to refractory asthma. Inflammation-guided management was superior for both discordant subgroups leading to a reduction in exacerbation frequency in the inflammation-predominant cluster (3.53 [SD, 1.18] vs. 0.38 [SD, 0.13] exacerbation/patient/yr, P = 0.002) and a dose reduction of inhaled corticosteroid in the symptom-predominant cluster (mean difference, 1,829 µg beclomethasone equivalent/d [95% confidence interval, 307–3,349 µg]; P = 0.02).

Conclusions: Cluster analysis offers a novel multidimensional approach for identifying asthma phenotypes that exhibit differences in clinical response to treatment algorithms.

Key Words: taxonomy • corticosteroid response • multivariate classification

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject Although several models of asthma classification have been proposed, a system defining the phenotypes of clinical asthma that incorporate the different aspects of the disease has not been developed. What This Study Adds to the Field Cluster analysis may be used to classify patients with asthma into phenotypic groups that exhibit clinically relevant differences in outcome with a management strategy using a measure of eosinophilic inflammation for titrating corticosteroid therapy.

 

This article has been cited by other articles:

				C. Samarghitean, C. Ortutay, and M. Vihinen Systematic Classification of Primary Immunodeficiencies Based on Clinical, Pathological, and Laboratory Parameters J. Immunol., December 1, 2009; 183(11): 7569 - 7575. [Abstract] [Full Text] [PDF]

				M. Weatherall, J. Travers, P. M. Shirtcliffe, S. E. Marsh, M. V. Williams, M. R. Nowitz, S. Aldington, and R. Beasley Distinct clinical phenotypes of airways disease defined by cluster analysis Eur. Respir. J., October 1, 2009; 34(4): 812 - 818. [Abstract] [Full Text] [PDF]

				S. Siddiqui and C. Brightling Magic Bullets: The New Goal for Asthma Am. J. Respir. Crit. Care Med., September 1, 2009; 180(5): 383 - 384. [Full Text] [PDF]

				J. H. T. Bates, M. Rincon, and C. G. Irvin Animal models of asthma Am J Physiol Lung Cell Mol Physiol, September 1, 2009; 297(3): L401 - L410. [Abstract] [Full Text] [PDF]

				J. C. de Jongste, S. Carraro, W. Hop, and E. Baraldi Cutoff Values for FENO-Guided Asthma Management Am. J. Respir. Crit. Care Med., August 1, 2009; 180(3): 282 - 282. [Full Text] [PDF]

				H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 59 - 99. [Abstract] [Full Text] [PDF]

				M. Gaga, E. Zervas, and P. Chanez Update on severe asthma: what we know and what we need Eur. Respir. Rev., June 1, 2009; 18(112): 58 - 65. [Full Text] [PDF]

				W. C. Moore Update in Asthma 2008 Am. J. Respir. Crit. Care Med., May 15, 2009; 179(10): 869 - 874. [Full Text] [PDF]

				A. Bush Update in Pediatric Lung Disease 2008 Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 637 - 649. [Full Text] [PDF]

				P. Haldar, C. E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, A. Sousa, R. P. Marshall, P. Bradding, R. H. Green, A. J. Wardlaw, et al. Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma N. Engl. J. Med., March 5, 2009; 360(10): 973 - 984. [Abstract] [Full Text] [PDF]

				S. E. Wenzel Eosinophils in Asthma -- Closing the Loop or Opening the Door? N. Engl. J. Med., March 5, 2009; 360(10): 1026 - 1028. [Full Text] [PDF]

				D. R. Taylor Exhaled Nitric Oxide: Still Alive, Not Laid to Rest Am. J. Respir. Crit. Care Med., January 15, 2009; 179(2): 88 - 89. [Full Text] [PDF]

				J. C. de Jongste, S. Carraro, W. C. Hop, the CHARISM Study Group, and E. Baraldi Daily Telemonitoring of Exhaled Nitric Oxide and Symptoms in the Treatment of Childhood Asthma Am. J. Respir. Crit. Care Med., January 15, 2009; 179(2): 93 - 97. [Abstract] [Full Text] [PDF]